focus -WSS

focus

author：focus 2025-08-12 08:29:55 - browse：195

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. We also discuss the latest news in the life sciences, including a twist in the future of Alnylam Pharmaceuticals, competition to Vertex Pharmaceuticals’ pain drug, and Gilead Sciences’ latest acquisition.

For more on what we cover, here’s all of Rachel’s coverage; here’s more on Vertex’s competition; here’s the news on Gilead; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

WSS

How medical schools plan to diversify without affirmative action

Clinical trials must include more disabled people

IRA could hurt research into orphan drugs for rare diseases

The pain doctors face in trying to build their families

New weight loss drugs vying to be the next Wegovy or Mounjaro

Will the IRA bring competition to the biologics market?

leisure time

focus

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Hilary expected to bring catastrophic, life

State Dept. review finds Biden bears some blame for Afghanistan failures

Trump's false claims about Georgia's 2020 election long debunked

Medical leaders decry Supreme Court decision on affirmative action

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Tori Bowie and the unacceptable rates of Black maternal death

FDA approves updated Covid vaccines

Walensky prepares to leave CDC — and Congress — behind

PEPFAR is under serious threat — and so is global health

explore

What to make of Biden’s latest efforts on cancer research

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

How medical schools plan to diversify without affirmative action

Trump cancels press conference intended to dispute Georgia election interference charges

Majority of Americans think Trump's Ga. election interference case is serious: POLL

What to make of Biden’s latest efforts on cancer research

focus

hotspot

focus

hotspot